An approach to medicine based on grouping patients according to the characteristics of their disease or how they respond to particular treatments (or to prophylaxis). This enables the identification and development of measures that are most effective for particular groups of patients.
A patient with B-cell acute lymphoblastic leukaemia has become the first adult to receive a pioneering cell therapy on the NHS...
The first 'lung-on-chip' model consisting solely of genetically identical cells derived from a single person can mimic breathing and simulate lung disease in an individual...
Rare genetic variants in a single gene appear to increase the risk of developing mental health conditions, according to a new study...
A new multipurpose genome editing approach could address around a third of rare genetic diseases...
Individual genes have been shown to produce multiple proteins, providing a potential insight into rare diseases that have previously lacked a clear explanation...
The UK government has committed to accelerating the development and approval of treatments for rare diseases, through major reforms to current regulation...
CAR-T cell cancer treatments could be made safer and more durable by reprogramming T cells without altering their DNA, according to new research...
Dr Rachel Starr and Professor Jonathan Smith review Interpretative Phenomenological Analysis in the context of genetic counselling and issues related to genetic and genomic medicine...
A world-first gene therapy has successfully been used to restore the immune system of a teenager with a rare genetic condition...
Genetic Alliance UK has been reviewing the 168-page document to understand what the Plan means for the 3.5 million people living with genetic, rare, and undiagnosed conditions in the UK...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
